Careers

C4U is a bio-venture company originated from Osaka University, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 technology.

CRISPR-Cas3 technology has strengths, such as its ability to induce large-scale deletions of DNA, its superior safety profile due to less concern about off-target deletion expression, and its freedom to operate (FTO) under patents.

C4U is currently conducting research and improvements to establish this technology as a genome editing platform that enables both knock-out and knock-in, and is expected to be utilised in a wide range of fields, including medicine (pharmaceuticals, diagnostics and gene therapy), biotechnology, agriculture and fisheries, and the environmental sector.

Carrier info

C4U is particularly aiming for applications in the medical field and is promoting collaborative research with pharmaceutical companies and others, while at the same time developing new therapies for genetic diseases in-house.

We are looking for researchers who will promote research and development together with us in order to deliver innovative new gene therapies to patients as quickly as possible.

Please contact us for details